Combination therapy with AG-490 and interleukin 12 achieves greater antitumor effects than either agent alone.
Year: 2002
Type: article
Source: PubMed
Institution: Moffitt Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Cancer Institute
OpenAlex ID: W2257921150
